Video-on-Demand Library

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

05 June 2018

Considerable interest has grown among pharmaceutical and other medical product developers in adaptive clinical trials, in which data collected during the course of a trial affects ongoing conduct or analysis of the trial. Following the release of the FDA draft Guidance document on adaptive design clinical trials in early 2010, expectations of an increase in regulatory submissions involving adaptive design features, particularly for confirmatory trials, were high. In this session we present a couple of case studies where adaptive designs were applied in a confirmatory setting as well as the statistical challenges resulting from the implementation of such designs. Recommendations will also be provided.

Part of Collection(s)

Topic(s)

Upcoming Events